Nicotine stimulates presynaptic nicotinic acetylcholine receptors in perivascular adrenergic nerves and releases unknown transmitter(s) that activate transient receptor potential vanilloid-1 (TRPV1) located on calcitonin gene-related peptide (CGRP)-containing (CGRPergic) nerves, resulting in vasodilation. The present study investigated a potential transmitter transmitting between perivascular adrenergic nerves and CGRPergic nerves. Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs' solution containing methoxamine, and the perfusion pressure and pH levels of the perfusate were measured. Nicotine perfusion for 1 min induced concentration-dependent vasodilation and lowered pH levels, which were abolished by cold-storage denervation of preparations, guanethidine (adrenergic neuron blocker), and mecamylamine (nicotinic ␣ 3 ␤ 4 -acetylcholine receptor antagonist). Capsazepine (TRPV1 antagonist) blunted nicotine-induced vasodilation, but had no effect on the reduction of pH. Injection of hydrochloric acid (HCl) and perfusion of Krebs' solution at low pH (6.0 -7.2) induced vasodilation. HClinduced vasodilation was inhibited by cold-storage denervation, capsazepine, capsaicin (CGRP depletor), and CGRP(8 -37) (CGRP receptor antagonist). Perfusion of adrenergic transmitter metabolites (normetanephrine and 3-methoxydopamine), but not of other metabolites, induced vasodilation, which was not inhibited by capsaicin treatment. Immunohistochemical staining of mesenteric arteries showed dense innervation of CGRP-and TRPV1-immunopositive nerves, with both immunostainings appearing in the same neuron. Mesenteric arteries were densely innervated by neuropeptide Y-immunopositive nerves, which coalesced with CGRP-immunopositive nerves. Scanning and immunoscanning electron microscopic images showed coalescence sites of different perivascular fibers before they intruded into smooth muscles. These results indicate that nicotine initially stimulates adrenergic nerves via nicotinic ␣ 3 ␤ 4 -receptors to release protons and thereby induces CGRPergic nerve-mediated vasodilation via TRPV1.
induced vasodilation was inhibited by cold-storage denervation, capsazepine, capsaicin (CGRP depletor), and CGRP(8 -37) (CGRP receptor antagonist). Perfusion of adrenergic transmitter metabolites (normetanephrine and 3-methoxydopamine), but not of other metabolites, induced vasodilation, which was not inhibited by capsaicin treatment. Immunohistochemical staining of mesenteric arteries showed dense innervation of CGRP-and TRPV1-immunopositive nerves, with both immunostainings appearing in the same neuron. Mesenteric arteries were densely innervated by neuropeptide Y-immunopositive nerves, which coalesced with CGRP-immunopositive nerves. Scanning and immunoscanning electron microscopic images showed coalescence sites of different perivascular fibers before they intruded into smooth muscles. These results indicate that nicotine initially stimulates adrenergic nerves via nicotinic ␣ 3 ␤ 4 -receptors to release protons and thereby induces CGRPergic nerve-mediated vasodilation via TRPV1.
It is widely accepted that vascular tone is maintained mainly by sympathetic adrenergic nerves via the release of the neurotransmitter norepinephrine. However, accumulating evidence reveals that nonadrenergic, noncholinergic (NANC) vasodilator nerves also play a role in regulation of vascular tone. We have demonstrated that the rat mesenteric artery has dense innervation of calcitonin gene-related peptide (CGRP)-containing (CGRPergic) nerves that release a transmitter, CGRP, causing vasodilation (Kawasaki et al., 1988) . Recently, we reported that nitric oxide (NO)-containing nerves innervating rat mesenteric arteries are involved in modulation of adrenergic neurotransmission (Hatanaka et al., 2006) . The rat mesenteric artery is also densely innervated by adrenergic nerves, which contain the main neuro-transmitter, norepinephrine, with a neuropeptide Y (NPY). Observations of double immunostainings in immunohistochemical studies showed the appearance of both NPY and CGRP immunoreactivities in the same neurons of the rat mesenteric artery (Eguchi et al., 2004) , leading to a hypothesis for some interactions between adrenergic nerves and CGRPergic nerves.
Our previous reports showed evidence that a functional deficiency in CGRPergic nerves augments adrenergic nervemediated vasoconstriction and, conversely, that adrenergic nerves via norepinephrine release presynaptically inhibit the neurogenic release of CGRP from the nerve, decreasing CGRPergic nerve function (Kawasaki et al., 1990a,b) . Thus, we have proposed that CGRPergic vasodilator nerves and sympathetic vasoconstrictor nerves reciprocally regulate the tone of the mesenteric resistance artery. Our recent studies revealed evidence that nicotine, a nicotinic acetylcholine (ACh) receptor agonist, induces perivascular adrenergic nerve-and CGRPergic nerve-mediated vasodilation in the rat mesenteric artery (Shiraki et al., 2000; Eguchi et al., 2004 Eguchi et al., , 2007 . In these studies, we proposed a hypothesis that nicotine stimulates nicotinic ACh receptors located on adrenergic nerves to release transmitter(s) that activate adjacent CGRPergic nerves through TRPV1 to induce CGRP-mediated vasodilation. Based on these studies, it is expected that nicotine releases an endogenous agonist for TRPV1 receptors from adrenergic nerves (Eguchi et al., 2004) . TRPV1 receptors have been shown to be stimulated by protons (H ϩ ) (Tominaga and Tominaga, 2005) , anandamide (Zygmunt et al., 1999) , and lipid metabolites (Van der Stelt and Di Marzo, 2004) . However, the substance(s) transmitting axo-axonal information from perivascular adrenergic nerves to CGRPergic nerves remain unclear. Therefore, the present study focused on possible endogenous agonist transmitters for TRPV1 involved in axo-axonal transmission of adrenergic nerves and CGRPergic nerves.
Materials and Methods

Animals
Male Wistar rats weighing 250 to 350 g were used in the present study. All animals were given food and water ad libitum. They were housed in the Animal Research Center of Okayama University at a controlled ambient temperature of 22 Ϯ 2°C with 50 Ϯ 10% relative humidity and a 12-h light/12-h dark cycle (light on, 8:00 AM). This study was performed in accordance with the Guidelines for Animal Experiments at Okayama University Advanced Science Research Center, Japanese Government Animal Protection and Management Law (115), and Japanese Government Notification on Feeding and Safekeeping of Animals (6). Every effort was made to minimize the number and suffering of animals used.
Perfusion of the Mesenteric Vascular Beds
The animals were anesthetized with pentobarbital-sodium (50 mg/kg i.p.), and the mesenteric vascular beds were isolated and prepared for perfusion as described previously (Kawasaki et al., 1988 (Kawasaki et al., , 1990a Shiraki et al., 2000) . In brief, the superior mesenteric artery was cannulated, and the entire intestine and associated vascular bed were isolated. The mesenteric vascular bed was separated from the intestine by cutting close to the intestinal wall. Only four main arterial branches from the superior mesenteric trunk running to the terminal ileum were perfused. The isolated mesenteric vascular bed was then placed in a water-jacketed organ bath maintained at 37°C and perfused with a modified (see below) Krebs' solution at a constant flow rate of 5 ml/min with a peristaltic pump (model AC-2120, ATTO Co., Tokyo, Japan). The preparation was also superfused with the same solution at a rate of 0.5 ml/min to prevent drying. The Krebs' solution was bubbled with a mixture of 95% O 2 -5% CO 2 before passage through a warming coil maintained at 37°C. The modified Krebs' solution had the following composition: 119.0 mM NaCl, 4.7 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgSO 4 , 25.0 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 0.03 mM disodium EDTA, and 11.1 mM dextrose, pH 7.4. Changes in the perfusion pressure were measured with a pressure transducer (model TP-400T; Nihon Kohden, Tokyo, Japan) and recorded by use of a pen recorder (model U-228; Nippon Denshi Kagaku, Tokyo, Japan).
In the series of experiments using Krebs' solution at different pH levels, Krebs' solution at pH 7.2, 7.0, 6.5, and 6.0 was prepared by reducing concentration of NaHCO 3 (pH 7.4, 20 mM) to 15, 5, 3, and 1 mM, respectively, and by increasing NaCl (pH 7.4, 120 mM) to 130, 140, 142, and 144 mM, respectively. The Krebs' solution at different pH levels containing methoxamine (1.5-2 M) was perfused for 1 min.
Chemical Removal of the Vascular Endothelium
The preparations with resting tone were perfused with a 1.8 mg/ml solution of sodium deoxycholate (SD) in saline for 30 s to remove the vascular endothelium, as described by Takenaga et al. (1995) and Shiraki et al. (2000) . The preparations then were rinsed with SD-free Krebs' solution for 60 min. After the preparations were contracted by perfusion with Krebs' solution containing methoxamine (2 M), successful removal of the endothelium was assessed by the lack of a relaxant effect after a bolus injection of 1 nmol of ACh, which was injected directly into the perfusate proximal to the arterial cannula with an infusion pump (model 975; Harvard Apparatus, Inc., Holliston, MA). The volume injected was 100 l over 12 s.
Periarterial Nerve Stimulation
Periarterial nerve stimulation (PNS) was applied for 30 s with use of bipolar platinum ring electrodes placed around the superior mesenteric artery. Rectangular pulses of 1 ms and a supramaximal voltage (50 V) were applied at 2 Hz with an electronic stimulator (model SEN 3301; Nihon Kohden).
In Vitro Treatment with Capsaicin
In vitro depletion of perivascular CGRP-containing nerves was performed according to the method described by Kawasaki et al. (1988 Kawasaki et al. ( , 1990a . The preparation was perfused with Krebs' solution containing capsaicin (CGRP depletor) (1 M) for 20 min and then rinsed for 60 min with capsaicin-free Krebs' solution. After the endothelium was removed with SD perfusion, the preparation was contracted by perfusion of Krebs' solution containing methoxamine (2 M). After the elevated perfusion pressure stabilized, a bolus injection of acetylcholine (1 nmol) was performed to check for the presence of the endothelium, and then PNS at 2 Hz was performed to check for the presence of CGRPergic nerves. Successful depletion of CGRPergic nerves was confirmed by the lack of a relaxant effect induced by periarterial nerve stimulation (2 Hz).
Cold-Storage Denervation
The isolated mesenteric vascular bed was stored in ice-cold Krebs' solution at 4°C for 72 h to achieve cold-storage denervation, as described previously (Kawasaki et al., 1991; Shiraki et al., 2000; Hobara et al., 2004) . After being perfused with Krebs' solution at 37°C for 60 min, the preparation was subjected to the experiment. After removal of endothelium by SD perfusion, the preparation was contracted by perfusion of Krebs' solution containing methoxamine (␣ 1 -adrenoceptor agonist). The concentration of methoxamine was increased to 5 to 7 M, because the cold-storage treatment decreased vasoconstrictor reactivity to methoxamine. To determine the vascular smooth muscle activity, a bolus injection of CGRP (50 pmol) was given to cause vasodilation. Successful denervation of periarterial nerves was confirmed by the lack of PNS-induced vasoconstriction (8 and 12 Hz) at resting tone and vasodilation (2 Hz) at active tone.
Measurement of pH Levels in the Perfusate
The isolated mesenteric vascular bed was perfused with Krebs' solution. A pH sensor was placed around the apical portion of each preparation, and changes in the pH value of the perfusate, which had flowed out from the preparation, were continuously monitored with the pH meter (model F-54; Horiba Co., Kyoto, Japan). Changes in pH levels were expressed as a percentage of pH values before perfusion of Krebs' solution containing the agents tested.
Measurement of Norepinephrine in the Perfusate
The isolated mesenteric vascular bed was perfused with Krebs' solution and the perfusate was collected before and after perfusion of nicotine for 3 min in the absence (control) or presence of guanethidine. Norepinephrine in the perfusate was adsorbed onto alumina and eluted with acetic acid. The eluate was assayed by high-performance liquid chromatography with electrochemical detection (model HTEC-500; Eicom, Kyoto, Japan). The internal standard was dihydroxybenzylamine.
Perfusion of Nicotine and Pharmacological Analysis
After chemical removal of the endothelium, the preparations were perfused with Krebs' solution containing methoxamine at a concentration of 2 M to induce submaximal vasoconstriction. After stabilization of the elevated perfusion pressure, Krebs' solution containing final concentrations of nicotine at 1, 10, or 100 M and methoxamine was perfused for 1 min as the control response, and then Krebs' solution containing methoxamine and guanethidine (adrenergic neuron blocker) (5 M), capsazepine (TRPV1 antagonist) (10 M), or mecamylamine (nicotinic ␣ 3 ␤ 4 -ACh receptor antagonist) (10 M) were perfused. After the elevated perfusion pressure had stabilized, Krebs' solution containing the final concentration of nicotine and guanethidine, capsazepine, or mecamylamine was perfused for 1 min. In the experiments using capsazepine (10 M), the concentration of methoxamine was increased to 10 M, because these antagonists caused vasodilation and weak active tone. To avoid tachyphylaxis, the perfusion of nicotine was carried out at 20-min intervals.
In the series of experiments using HCl, bolus injections of 0.1 mol of HCl were given during perfusion of capsazepine (10 M) and CGRP(8 -37) (0.1 M; CGRP receptor antagonist) and in preparations treated with capsaicin (1 M) or with cold-storage denervation.
In the series of experiments using various catecholamine metabolites, Krebs' solution containing methoxamine and a concentration of catechol-O-methyltransferase (COMT) metabolite of dopamine (3-methoxytyramine, homovanillic acid), norepinephrine (normetanephrine, vanillylmandelic acid), monoamine oxidase (MAO) metabolite of dopamine (3,4-dihydroxyphenyl acetic acid), or norepinephrine (3,4-dihydroxymandelic acid) were perfused for 1 min in rat denuded mesenteric vascular beds treated with or without capsaicin.
At the end of each experiment, the preparations were perfused with 100 M papaverine to induce complete relaxation. Vasodilator activity is expressed as the percentage of perfusion pressure at the maximal relaxation induced by papaverine.
Immunohistochemical Study
Confocal Laser Microscopy. Under pentobarbital-Na anesthesia, the mesenteric artery with the intestine was surgically removed and the third-order branch of the artery was isolated and fixed in Zamboni's fixative containing 2% paraformaldehyde and 15% picric acid in 0.15 M phosphate buffer for 48 h. After fixation, the specimens were rinsed repeatedly in phosphate-buffered saline (PBS). The mesenteric artery was immersed in PBS containing 0.5% Triton X-100 overnight, followed by incubation with PBS containing normal goat serum (1:100) for 60 min. The tissues were then incubated with the primary antibody/anti-TRPV1 (1:10,000; raised in rabbit) (ABRAffinity BioReagents, Golden, CO) or anti-NPY (1:300; raised in rabbit) (Phoenix Pharmaceuticals, Belmont, CA) for 72 h at 4°C. After incubation, the tissues were washed in PBS, and the site of the antigen-antibody reaction was revealed by incubation with fluorescein-5-isothiocyanate-labeled goat anti-rabbit IgG (diluted 1:100) (Valeant Pharmaceuticals, Costa Mesa, CA) for 60 min. The tissues were thoroughly washed in PBS, mounted in glycerol/PBS 2:1 (v/v), and observed under a confocal laser scanning microscope (CLSM 510; Carl Zeiss GmbH, Jena, Germany). Control immunohistochemical staining for TRPV1 was done by preabsorbing the blocking peptide for the primary antibody to TRPV1 (rat) (20 g/ml; Alexis Laboratories, San Diego, CA) and exhausting the TRPV1 antibody with the relevant peptides. Double Immunostainings. Mesenteric arteries were incubated with PBS containing 1% normal goat serum, 1% bovine serum albumin, and 0.03% Triton X-100 for 1 h. The sections then were incubated with an anti-TRPV1 antibody (1:10,000; raised in rabbit) or anti-NPY antibody (1:300; raised in rabbit) (Phoenix Pharmaceuticals) at 4°C for 2 days, followed by incubation with an anti-CGRP antibody (1:300; raised in guinea pig) at 4°C for 2 days. After washes in PBS, the sections were incubated for 2 h with rhodamine-conjugated goat F(abЈ) 2 fraction anti-guinea pig IgG (diluted 1:100) (Valeant Pharmaceuticals) at 4°C, followed by incubation with fluorescein-5-isothiocyanate-conjugated rabbit IgG fractions (diluted 1:100) (Valeant Pharmaceuticals) at 4°C for 1 h. The samples were then observed under a confocal laser scanning microscope (CLSM 510; Carl Zeiss) with an exciting filter system (458/488 nm for fluorescein-5-isothiocyanate) and an emission filter system (543 nm for rhodamine). Two fluorescence views were obtained from the same microscopic field.
Scanning Electron Microscopic Study
Tissue Processing. Under pentobarbital-Na anesthesia, mesenteric arteries were isolated, excised, fixed with 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, for 12 h at 4°C, and then rinsed in 0.1 M phosphate buffer for 10 min and treated with 30% KOH solution at 60°C for 10 min to dissolve connective tissue matrices around vessels. The specimens were immersed in 0.5% tannic acid solution for 1 h and then postfixed with 1% osmium tetroxide in 0.1 M phosphate buffer for 1 h. The samples were rinsed with 0.1 M phosphate buffer and then dehydrated through a graded series of ethanol and dried with t-butyl alcohol by use of a critical-point drier. They were observed in a scanning electron microscope (S-2300; Hitachi Software Engineering, Yokohama, Japan) under an accelerating voltage of 25 kV.
Immunoscanning Electron Microscopy. Under pentobarbital-Na anesthesia, the second-and third-order branches of the mesenteric arteries were isolated, dissected out, and placed in Zamboni's fixative containing 2% paraformaldehyde and 15% picric acid in 0.15 M phosphate buffer for 48 h. After fixation, the arteries were rinsed repeatedly with PBS, immersed in PBS containing 0.5% Triton X-100 for 48 h, and then incubated with PBS containing normal goat serum (1:100) for 60 min. The arteries were then incubated with the primary antibodies: anti-tyrosine hydroxylase (rate-limiting enzyme of tyrosine in adrenergic nerves) (TH; 1:300; raised in rabbits; Phoenix Pharmaceuticals) or anti-CGRP (1:500; raised in rabbits; BIOMOL Research Laboratories, Plymouth Meeting, PA) for 72 h at 4°C. After incubation, the arteries were washed with PBS and incubated for 30 min with a horseradish peroxidase-conjugated secondary antibody (1:100; R&D Systems, Inc., Minneapolis, MN) for 3 h at 4°C. The antigen-antibody complex was then visualized by incubating the arteries with 3,3Ј-diaminobenzidine solution (3,3Ј-diaminobenzidine 12 mg/ml, 1 ml of Tris-HCl at pH 7.4 and 3% H 2 O 2 ) for 15 to 30 min. The arteries were then fixed with 2% glutaraldehyde in a 0.1 M phosphate buffer (pH 7.4) for 12 h at 4°C, rinsed in 0.1 M phosphate buffer for 10 min, and treated with 30% KOH solution at Proton as an Axo-Axonal Neurotransmitter 747 at ASPET Journals on April 9, 2017 jpet.aspetjournals.org 60°C for 10 min to dissolve connective tissue matrices around vessels. The specimens were immersed in 0.5% tannic acid solution for 1 h and then postfixed with 1% osmium tetroxide in 0.1 M phosphate buffer, pH 7.4, for 1 h. The samples were washed with phosphate buffer, dehydrated through a graded series of ethanol, and dried with t-butyl alcohol using a critical-point drier. They were observed in a scanning electron microscope (S-900; Hitachi) under an accelerating voltage of 10 or 15 kV.
Statistical Analysis
Experimental results are presented as the mean Ϯ S.E.M. Statistical analysis was done using the Student's unpaired t test and one-way analysis of variance followed by Tukey's test. A P Ͻ 0.05 was considered significant.
Drugs
The following drugs were used: ACh chloride (Daiichi Sankyo, Tokyo, Japan), capsaicin (Sigma-Aldrich, St. Louis, MO), capsazepine (SigmaAldrich), 3,4-dihydroxyphenyl acetic acid (Sigma-Aldrich), 3,4-dihydroxymandelic acid (Sigma-Aldrich), guanethidine sulfate (Tokyo Kasei, Tokyo, Japan), homovanillic acid (Sigma-Aldrich), human CGRP(8 -37) (Peptide Institute, Osaka, Japan), dihydroxybenzylamine (Sigma-Aldrich), 3-methoxytyramine (Sigma-Aldrich), normetanephrine (Sigma-Aldrich), norepinephrine hydrochloride (Daiichi Sankyo), nicotine tartrate salt (Sigma-Aldrich), mecamylamine (Sigma-Aldrich), methoxamine hydrochloride (Nihon Shinyaku Co., Kyoto, Japan), papaverine hydrochloride (Sigma-Aldrich), rat CGRP (Peptide Institute), SD (Ishizu Seiyaku, Tokyo, Japan), and vanillylmandelic acid (SigmaAldrich). All drugs, except for capsaicin and SD, were dissolved in pure water and diluted with Krebs' solution. Capsaicin was dissolved in 50% ethanol and diluted with Krebs' solution (final alcohol concentration, 0.4 mg/ml). SD was dissolved in 0.9% saline. ACh and rat CGRP were diluted with Krebs' solution containing 2 M methoxamine when injected directly.
Results
Vasodilator Response and pH Changes Induced by Nicotine Perfusion. As shown in Fig. 1A , in the SD-treated preparation with active tone produced by methoxamine, bolus injection of ACh did not induce a vascular response, indicating that the endothelium had lost its function. PNS at 1 Hz caused an initial increase in perfusion pressure due to vasoconstriction, followed by long-lasting decrease in perfusion pressure due to vasodilation, indicating that perivascular nerve function was left intact. PNS-induced vasoconstriction and vasodilation have been shown to be mediated by adrenergic nerves and CGRPergic nerves, respectively (Kawasaki et al., 1988; Takenaga et al., 1995) .
In this preparation, perfusion of nicotine caused a concentration-dependent vasodilation (Fig. 1A) . Basal pH levels of the perfusate before the first and second series of nicotine perfusion was 7.547 Ϯ 0.061 (n ϭ 9) and 7.454 Ϯ 0.103 (n ϭ 9), respectively. The nicotine perfusion decreased perfusate pH values (Fig. 1B) , which appeared during the vasodilation, started within 1 min after nicotine perfusion, reached a maximum at 5 to 7 min, and then returned to preperfusion pH levels (Fig. 1B) . As shown in Fig. 2 , the nicotine-induced vasodilation ( Fig. 2A ) and pH lowering (Fig. 2B ) was concentration-dependent and reproducible when nicotine perfusion was repeated. In some preparations, a very slight vasoconstriction by nicotine at low concentrations of 1 to 10 M preceded the vasodilation, but no vasoconstriction to nicotine was observed at higher concentrations (data not shown).
In preconstricted preparations treated with cold storage, PNS at 2 Hz did not cause a vascular response (data not shown), indicating that function of perivascular nerves had been effectively eliminated. As shown in Fig. 2C , in denervated preparations, perfusion of nicotine induced neither vasodilation nor a pH lowering (Fig. 2D) . Basal pH levels of the perfusate before the first series of nicotine perfusion was 7.667 Ϯ 0.043 (n ϭ 3).
As shown in Fig. 3 , the nicotine-induced vasodilation (Fig.  3A) and pH lowering (Fig. 3B) were abolished by guanethidine, which eliminated PNS-induced adrenergic nerve-medi- ated vasoconstriction, but not CGRPergic nerve-mediated vasodilation (data not shown). Basal pH levels of the perfusate before the first (control) and second (guanethidine) series of nicotine perfusion was 7.545 Ϯ 0.089 (n ϭ 5) and 7.510 Ϯ 0.060 (n ϭ 5), respectively. Figure 3 , C and D, shows that mecamylamine markedly inhibited vasodilation and the pH lowering induced by nicotine perfusion, respectively. Basal pH levels of the perfusate before the first (control) and second (mecamylamine) series of nicotine perfusion was 7.494 Ϯ 0.072 (n ϭ 5) and 7.502 Ϯ 0.074 (n ϭ 5), respectively.
As shown in Fig. 3E , capsazepine markedly inhibited nicotine-induced vasodilation, while the antagonist did not affect the nicotine-induced pH lowering, but rather enhanced it (Fig. 3F) . Basal pH levels of the perfusate before the first (control) and second (capsazepine) series of nicotine perfusion was 7.589 Ϯ 0.129 (n ϭ 5) and 7.450 Ϯ 0.250 (n ϭ 5), respectively.
Vasodilator Response Induced by HCl (H ؉ ) Injection. In perfused mesenteric vascular beds without endothelium, as shown in Fig. 4A , a bolus injection of HCl induced an initial sharp vasodilation followed by a long-lasting vasodilation (80.4 Ϯ 6.4%, n ϭ 5), whereas NaCl injection had no effect (0.6 Ϯ 0.02%; n ϭ 3), indicating that protons (H ϩ ), but not chloride anion (Cl Ϫ ), were responsible for the vasodilation. Bolus injection of HCl lowered pH levels of the perfusate from 7.692 Ϯ 0.054 (basal pH level; n ϭ 3) to 7.58 Ϯ 0.52 (1.45% decrease; n ϭ 3), whereas NaCl injection did not change pH levels of perfusate (basal pH, 7.693 Ϯ 0.047; pH after NaCl injection, 7.686 Ϯ 0.039; 0.09% decrease; n ϭ 3). Figure 4B showed that the HCl-induced vasodilation was significantly inhibited by cold-storage denervation, capsazepine, CGRP(8 -37), and capsaicin treatment.
Vasodilator Response Induced by Perfusion of
Krebs' Solution at Different pH Levels. In perfused mesenteric vascular beds without endothelium, as shown in Fig.  5A , perfusion of Krebs' solution at 7.2, 7.0, 6.5, or 6.0 for 1 min induced a sharp vasodilation in a pH-dependent manner (Fig. 5B) . However, perfusion of Krebs' solution at pH 7.4 did not cause vasodilation (Fig. 5) .
Norepinephrine Release Induced by Nicotine. In rat perfused mesenteric vascular beds with active tone, spontaneous release of norepinephrine was detected in the perfusate (273.4 Ϯ 99 pg/ml, n ϭ 7). As shown in Fig. 6 , a 1-min perfusion of nicotine at a concentration of 100 M significantly increased norepinephrine levels (345.7 Ϯ 120 pg/ml, n ϭ 7, P Ͻ 0.05) in the perfusate 2 min after the perfusion, compared with preperfusion levels. Increased norepinephrine levels were observed until 10 min after nicotine perfusion. In the presence of guanethidine, spontaneous release of norepinephrine was also detected in the perfusate (183.7 Ϯ 68 pg/ml, n ϭ 4). Guanethidine abolished the norepinephrine release induced by nicotine at 2 min after the perfusion (188.3 Ϯ 70 pg/ml, n ϭ 4) and throughout the experiment (Fig. 6) .
Vascular Responses to Perfusion of Various Catecholamine Metabolites. As shown in Table 1 , perfusion of 3-methoxytyramine (COMT metabolite of dopamine) and normetanephrine (COMT metabolite of norepinephrine) induced concentration-dependent vasodilation in rat denuded mesenteric vascular beds. However, capsaicin treatment, which abolished nicotine-induced vasodilation (Shiraki et al., 2000) , did not affect the vasodilation induced by the two metabolites (Table 1) . As shown in Table 1 , a MAO-metabolite (3,4-dihydroxyphenyl acetic acid) of dopamine and its COMT metabolite (homovanillic acid) and MAO metabolite Immunohistochemical Studies of Perivascular Nerves. Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP-like immunoreactivities (LI) fibers (Fig. 7A ) and adrenergic NPY-LI fibers (Fig. 7B) . Innervation of NPY-LI fibers was greater than that of CGRP-LI fibers (Fig. 7) . As shown in Fig. 7 , C and D, double immunostainings showed that most CGRP-LI fibers in contact with NPY-LI fibers appeared as yellow fibers when merged, indicating that there were close contact sites between adrenergic and CGRPergic nerves.
Figures 7E and 6F show CGRP-LI fibers and TRPV1-LI fibers in the same area of the rat mesenteric artery, respectively. In addition, as shown in Fig. 7G , double immunostainings showed that both immunostainings appeared in the same neuron when merged.
Scanning Electron Microscopic Study. Figure 8A shows a scanning electron microscopic image of perivascular nerve fibers in the mesenteric artery with many fibers running on vascular smooth muscles. In addition, the image showed that several fibers or two fibers had coalescence sites (Fig. 8A , asterisks) before they intruded into vascular smooth muscles (Fig. 8A, arrows) . In addition, Fig. 8B shows coalesced nerve fibers (asterisk) and synapse-like contact between two different fibers (a and b) was observed in Fig. 8C . Figure 9 shows immunoscanning electron microscopic images of CGRP (Fig. 9A ) and tyrosine hydroxylase-(TH; Fig.  9B ) immunoreactive nerve fibers, which are observed as light-red colors. As shown in Fig. 9A , CGRP-immunoreactivity-containing nerves were thin and linear fibers with a smooth surface, whereas TH-immunoreactivity-containing nerves as observed in Fig. 9B were thick and winding fibers with a rough surface. Figure 9B also shows that TH-immunoreactivity-containing nerves (a) had coalescence sites (c) with different nerves (b), which did not contain immunoreactivities and were thin and linear fibers similar to the CGRP-immunoreactivity-containing fibers in Fig. 9A .
Discussion
The rat mesenteric resistance artery has innervation of adrenergic vasoconstrictor nerves and NANC vasodilator nerves in which CGRP, a potent vasodilator peptide, acts as a vasodilator neurotransmitter (Kawasaki et al., 1988 (Kawasaki et al., , 1990a . Inhibition of CGRPergic function by capsaicin and CGRP(8 -37) augmented adrenergic nerve-mediated vasoconstriction in response to field stimulation, suggesting that CGRPergic nerves suppress sympathetic nerve-mediated vasoconstriction (Kawasaki et al., 1990a) . Conversely, CGRPergic nerve-mediated vasodilation was blunted by ␣ 2 -adrenoceptor agonists (clonidine and norepinephrine) and NPY without affecting exogenous CGRP-induced vasodilation, suggesting that sympathetic nerves presynaptically inhibit the release of CGRP from the nerve decreasing CGRPergic nerve function (Kawasaki et al., 1990b (Kawasaki et al., , 1991 . Thus, we proposed that CGRPergic vasodilator nerves along with sympathetic vasoconstrictor nerves reciprocally regulate the tone of the mesenteric resistance artery.
The present immunohistochemical study confirmed previous findings that rat mesenteric arteries were densely innervated by NPY-LI and CGRP-LI nerve fibers. The NPY-LI innervation has been shown to be eliminated by cold-storage denervation and 6-hydroxydopamine (adrenergic neurotoxin), but not capsaicin, whereas CGRP-LI fibers were abolished by cold-storage denervation and capsaicin, but not 6-hydroxydopamine , indicating that CGRPergic nerves are capsaicin-sensitive and different from adrenergic nerves. In the present additional study, double immunostainings showed both NPY-LI and CGRP-LI nerve fibers in the same neuron of the rat mesenteric artery. This a bar graph (B) showing the effects of various agents and treatments on HCl-induced vasodilation in rat mesenteric vascular beds without endothelium. Each bar indicates means Ϯ S.E.M. in preparations without treatment (Control; n ϭ 6) and with treatment of coldstorage denervation (Denervation; n ϭ 6), 10 M capsazepine (Capsazepine; n ϭ 4), 0.1 M CGRP(8 -37) (n ϭ 4), and 1 M capsaicin (n ϭ 4). ACh, PNS, and PPV indicate a bolus injection of acetylcholine (1 nmol), periarterial nerve stimulation (2 Hz), and perfusion of papaverine (100 M). SD, perfusion of sodium deoxycholate. ‫ء‬ P Ͻ 0.05; ‫ءء‬ P Ͻ 0.01 versus Control. finding is in accordance with results reported by Eguchi et al. (2004) . In addition, the scanning electron microscopic study suggests that perivascular nerves have coalescence sites, probably CGRPergic nerves and sympathetic adrenergic nerves. Furthermore, immunoscanning electron microscopic study using anti-CGRP for CGRPergic nerves and anti-TH for adrenergic nerves showed evidence that TH-immunoreactivity-containing nerves, adrenergic nerves, have coalescence sites with different nerves with different transmitters, probably CGRPergic nerves. Taken together, these findings strongly suggest that there are close-contact areas between adrenergic and CGRPergic nerves and that both nerves interact at these areas.
Our previous studies showed that in rat perfused mesenteric vascular beds with active tone and without endothelium, perfusion of nicotine and nicotinic ACh receptor agonists (cytisine and epibatidine) caused concentrationdependent vasodilation without inducing vasoconstriction (Shiraki et al., 2000; Eguchi et al., 2007) . The nicotine-induced vasodilation was abolished by cold-storage denervation, suggesting that perivascular nerves are responsible for the effect of nicotine. In addition, vasodilation induced by nicotine and nicotinic ACh receptor agonists was blunted by the adrenergic neuron blocker guanethidine and CGRP depletor capsaicin, suggesting that intact adrenergic nerves and CGRPergic nerves mediate the vasodilation (Shiraki et al., 2000; Eguchi et al., 2007) . Furthermore, mecamylamine (␣ 3 ␤ 4 -nicotinic ACh receptor antagonist), but not ␣-bungarotoxin (␣ 7 -nicotinic ACh receptor antagonist) or dihydro-␤-erythroidine (␣ 4 ␤ 2 -nicotinic ACh receptor antagonist), abolished the nicotine-and nicotinic ACh receptor agonistinduced vasodilation (Eguchi et al., 2007) . Therefore, based on these results, it can be hypothesized that nicotine initially stimulates ␣ 3 ␤ 4 -nicotinic ACh receptors, which are located on adrenergic nerves, to release adrenergic neurotransmitter(s) and related substances. These released substances activate receptors located on adjacent CGRP nerves and then release CGRP, causing vasodilation.
To clarify possible substances transmitting nicotine-induced vasodilation, our previous study investigated using several antagonists, which antagonize the effect of adrenergic neurotransmitters (Eguchi et al., 2004) . However, this study showed that the nicotine-induced vasodilation was not inhibited by L-NAME (NO synthase inhibitor), propranolol (nonselective ␤-adrenoceptor antagonist), 3,4-dihydroxyphenylalanine cyclohexyl ester (3,4-dihydroxyphenylalanine receptor antagonist) (Misu et al., 1997) , SCH23390 (selective dopamine D 1 receptor antagonist), haloperidol (dopamine D 2 receptor antagonist), ␣,␤-methylene ATP (ATP P 2x receptordesensitizing agonist), 8-(p-sulfophenyl)theophylline (adenosine A 2 receptor antagonist), or BIBP3226 (NPY-Y1 receptor antagonist) (Eguchi et al., 2004) . In the present study, perfusion of 3-methoxytyramine (COMT metabolite of dopamine) and normetanephrine (COMT metabolite of norepinephrine), but not other MAO and COMT metabolites of dopamine and norepinephrine, induced concentration-dependent vasodilation in rat denuded-mesenteric vascular beds. However, capsaicin treatment, which abolished nicotine-induced vasodilation, did not affect the vasodilation induced by either metabolite, suggesting that capsaicin-sensitive CGRPergic nerves are not responsible for vasodilation induced by the two metabolites. Taken together, it is unlikely that catecholamines, catecholamine metabolites, or other transmitters, which are released from perivascular adrenergic nerves, are involved in the nicotine-induced vasodilation.
The present and previous studies with immunohistochemical staining of the mesenteric artery showed dense innerva-TABLE 1 Vascular responses induced by nicotine, dopamine metabolites (3-methoxytyramine, 3,4-dihydroxyphenylacetic acid homovanillic acid) and norepinephrine metabolites (normethanephrine, 3,4-dihydroxymandelic acid, and vanillylmandelic acid) in rat perfused mesenteric vascular beds without endothelium and with active tone tion of CGRP-LI-and TRPV1-LI-immunopositive nerves, with both immunostainings appearing in the same neuron (Eguchi et al., 2004) . Therefore, these results strongly suggest that CGRPergic nerves innervating mesenteric arteries have TRPV1. Furthermore, the present and previous studies demonstrated that capsazepine (selective TRPV1 antagonist) and ruthenium red (inhibitor of TRPV1 response) inhibited nicotine-induced vasodilation without affecting vasodilation in response to exogenously applied CGRP (Eguchi et al., 2004) , suggesting that TRPV1 is involved in the nicotineinduced vasodilation. It is well known that the primary sensory nerves are activated by protons (H ϩ ) via TRPV1 (Tominaga and Tominaga, 2005) . In the present study, exogenously applied HCl in rat mesenteric vascular beds without endothelium resulted in endothelium-independent vasodilation associated with pH lowering of the perfusate. Because NaCl injection had no vascular effect, H ϩ , but not Cl Ϫ , is responsible for the HClinduced vasodilation. In addition, cold-storage denervation, capsaicin treatment, and CGRP(8 -37) markedly inhibited HCl-induced vasodilation, suggesting that it is neurogenic and mediated by capsaicin-sensitive CGRPergic nerves. The finding that capsazepine and CGRP(8 -37) inhibited the HClinduced vasodilation clearly suggest that H ϩ activates TRPV1 in the CGRPergic nerves and results in CGRP-mediated vasodilation. Furthermore, perfusion of Krebs' solution at low pH levels of 6.0 to 7.2 induced pH-dependent vasodilation as observed in nicotine perfusion. The synergic effects of H ϩ and Krebs' solution at low pH levels with nicotine imply that protons mediate nicotine-induced vasodilation and act as a transmitter from adrenergic nerves to CGRPergic nerves.
To confirm that protons are a transmitter for mediating nicotine-induced vasodilation, we measured pH levels of the perfusate concomitant with nicotine-induced vasodilation. The results showed that the pH levels decreased as the nicotine-induced vasodilation appeared. Furthermore, a pharmacological study showed that the nicotine-induced pH lowering, and the vasodilation was abolished by cold-storage denervation, guanethidine, and mecamylamine. Therefore, it is very likely that nicotine stimulates ␣ 3 ␤ 4 -nicotinic ACh receptors to release protons from adrenergic nerves. The released protons activate TRPV1 in the adjacent CGRPergic nerves, releasing CGRP and causing vasodilation. However, capsazepine did not affect the nicotine-induced pH lowering of the perfusate, whereas the antagonist inhibited the vaso- jpet.aspetjournals.org dilation. The contradictory effect of capsazepine may be explained by the hypothesis that capsazepine, which has already bound to TRPV1, blocks protons released by nicotine to bind to TRPV1. Therefore, unbound protons in the presence of capsazepine overflow and result in no change or even a greater decrease in pH levels. In addition, capsazepine blunts vasodilation mediated by CGRPergic nerves due to blockade of TRPV1 activation by protons.
Nicotine has been shown to stimulate the release of neurotransmitters such as norepinephrine, NPY (Haass et al., 1991) , and ATP (Von Kü gelgen and Starke, 1991) from adrenergic nerve terminals. These results are confirmed by the present finding that nicotine evoked release of norepinephrine, which was abolished by guanethidine. It is widely accepted that the neurotransmitter norepinephrine is stored in adrenergic nerve terminal vesicles and is released into the synapse during signal transduction, spilling norepinephrine and other contents of the vesicle through exocytosis. Norepinephrine in the cytoplasm of the nerve terminal is transported into vesicles using energy provided by the proton gradient, causing protons to be more concentrated inside the vesicle where pH levels are low at 5.5 (Wu et al., 2001 ). This implies that vesicles in adrenergic nerve terminals contain protons to store the transmitter norepinephrine. Therefore, it is likely that protons accompanied by norepinephrine release are released from adrenergic nerves when exocytosis occurs. This notion also suggests that nicotine releases protons from adrenergic nerves because it evoked norepinephrine release. Furthermore, primary studies showed that periarterial nerve stimulation of perfused mesenteric arteries resulted in a decrease in pH levels of the perfusate concomitant with initial adrenergic nerve-mediated vasoconstriction followed by CGRPergic nerve-mediated vasodilation, which were abolished by cold-storage denervation. Guanethidine blunted the initial adrenergic vasoconstriction and pH lowering, but it did not affect vasodilation induced by stimulation of CGRPergic nerves. These findings also suggest that protons act as a transmitter for axo-axonal transmission between adrenergic and CGRPergic nerves in mesenteric resistance arteries. Lee et al. (2000) and Si and Lee (2001) reported that nicotine induces vasodilation in the porcine basilar arteries, which is blocked by guanethidine, ␣-bungarotoxin, and N -nitro-L-arginine methyl ester, suggesting the hypothesis that nicotine directly acts on presynaptic adrenergic nerve terminals, causing the release of noradrenaline, which then acts on presynaptic ␤-adrenoceptors located on the NO-containing nerve terminals, resulting in the release of NO and dilation of porcine basilar arteries. These reports are in accordance with the present findings and the hypothesis that nicotine directly stimulates nicotinic acetylcholine receptors on adrenergic nerves to release norepinephrine, which then stimulates TRPV1 on adjacent CGRP-containing nerves to release CGRP and cause vasodilation. In addition, these reports and the present findings did not show vasoconstrictor response to nicotine despite the release of norepinephrine. Therefore, it is inferred that coalescence sites between adrenergic nerves and CGRPergic nerves, where axo-axonal interaction occurs, may locate outside smooth muscle cells. It is also assumed that nicotinic acetylcholine receptors are only distributed in adrenergic nerves at axo-axonal sites, whereas adrenergic nerves at neuro-effector (smooth muscle) at ASPET Journals on April 9, 2017 jpet.aspetjournals.org sites may not be endowed with nicotinic acetylcholine receptors. However, the different distribution of nicotinic acetylcholine receptors in perivascular nerves needs to be clarified.
In conclusion, the rat mesenteric resistance arteries are densely innervated by adrenergic vasoconstrictor nerves and NANC CGRPergic vasodilator nerves, which have close contact sites. These nerves have axo-axonal interactions that modulate the vascular nerve function and regulate vascular tone. Our results strongly suggest involvement of protons (H ϩ ) in nicotine-induced vasodilation; we hypothesize, as shown in Fig. 10 , that nicotine acts on presynaptic nicotinic ␣ 3 ␤ 4 -receptors in adrenergic nerves to release protons together with the adrenergic neurotransmitter norepinephrine via exocytosis and then the released protons stimulate TRPV1 receptors on neighboring CGRPergic nerves, resulting in CGRP-mediated vasodilation.
